Literature DB >> 18593438

Regulatory T cells in a spectrum of HPV-induced cervical lesions: cervicitis, cervical intraepithelial neoplasia and squamous cell carcinoma.

Sreenivas Adurthi1, Sudhir Krishna, Geetashree Mukherjee, Uttamchand Deepak Bafna, Uma Devi, Rudrapatna Subramanyam Jayshree.   

Abstract

PROBLEM: Thriving of tumors amidst rich immune infiltrates is an unexplained paradox. METHOD OF STUDY: Immune markers on lymphocytic infiltrates in HPV-positive cervicitis, cervical intraepithelial neoplasia III (CIN III), squamous cell carcinoma (SCC) and normal cervices were characterized immunohistochemically. Regulatory T cells were enumerated and phenotypically characterized using antibodies to FOXP3.
RESULTS: SCCs had higher numbers of CD4 and CD8 cells; infiltrates expressed more CD25, TGFbeta, and IL10 but had significantly lower IL2 compared with cervicitis and CIN III. Expression of CD25 and IL2 correlated well in cervicitis and CIN III but not in SCC. FOXP3 expression was also higher and ratios of CD4/FOXP3 and CD8/FOXP3 were lower in SCC. A fraction of cervicitis, CIN I, CIN II and CIN III had natural (n) regulatory T cells (Tregs); their lesional distribution was predominantly intraepithelial in cervicitis, while in CIN they were also present in the stroma. The proportion of FOXP3(+) CD25(+); FOXP3(+) CD25(-) and TGFbeta(+) CD25(+) in invasive tumors was 17; 19 and 22 respectively.
CONCLUSION: Cervical tumors are marked by the presence of an immunoregulatory environment, and harbor equal proportions of 'inactive' n Tregs; activated n Tregs; and Tregs operating via TGFbeta. nTregs in cervicitis and CIN may be a potential marker of persistence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18593438     DOI: 10.1111/j.1600-0897.2008.00590.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  22 in total

1.  Location and Density of Immune Cells in Precursor Lesions and Cervical Cancer.

Authors:  Astrid M Bedoya; Roberto Jaramillo; Armando Baena; Jorge Castaño; Natalia Olaya; Arnold H Zea; Rolando Herrero; Gloria I Sanchez
Journal:  Cancer Microenviron       Date:  2012-01-31

2.  Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer.

Authors:  Dan Song; Hong Li; Haibo Li; Jianrong Dai
Journal:  Oncol Lett       Date:  2015-05-29       Impact factor: 2.967

3.  Pathologic and imunohistochemical characterization of tumoral inflammatory cell infiltrate in invasive penile squamous cell carcinomas: Fox-P3 expression is an independent predictor of recurrence.

Authors:  José Vassallo; André Fellipe Freitas Rodrigues; Antonio Hugo J F M Campos; Rafael Malagoli Rocha; Isabela Werneck da Cunha; Stênio Cássio Zequi; Gustavo Cardoso Guimarães; Francisco Paulo da Fonseca; Ademar Lopes; Antonio Cubilla; Fernando Augusto Soares
Journal:  Tumour Biol       Date:  2015-01-05

4.  Naive and radiolabeled antibodies to E6 and E7 HPV-16 oncoproteins show pronounced antitumor activity in experimental cervical cancer.

Authors:  R Phaëton; J Gutierrez; Z Jiang; R G Karabakhtsian; J Albanese; J Sunkara; D R Fisher; G L Goldberg; E Dadachova
Journal:  Immunotherapy       Date:  2015-06-22       Impact factor: 4.196

5.  Increased numbers of Foxp3-positive regulatory T cells in gastritis, peptic ulcer and gastric adenocarcinoma.

Authors:  Hsin-Hung Cheng; Guan-Ying Tseng; Hsiao-Bai Yang; Hung-Jung Wang; Hwai-Jeng Lin; Wen-Ching Wang
Journal:  World J Gastroenterol       Date:  2012-01-07       Impact factor: 5.742

6.  Role of FoxP3-positive regulatory T-cells in regressive and progressive cervical dysplasia.

Authors:  Linda Hertlein; Thomas Kolben; Aurelia Vattai; Nadine Kremer; Sarah Meister; Susanne Beyer; Lucia Keilmann; Anna Hester; Mina Temelkov; Helene Heidegger; Elisa Schmoeckel; Mirjana Kessler; Sven Mahner; Udo Jeschke
Journal:  J Cancer Res Clin Oncol       Date:  2021-11-05       Impact factor: 4.553

7.  Role of estrogen receptor alpha in human cervical cancer-associated fibroblasts: a transcriptomic study.

Authors:  Mahesh M Kumar; Sravanthi Davuluri; Sridhar Poojar; Geetashree Mukherjee; Akhilesh Kumar Bajpai; Uttam Dungarmal Bafna; Uma K Devi; Pramod P R Kallur; Acharya K Kshitish; R S Jayshree
Journal:  Tumour Biol       Date:  2015-10-24

Review 8.  Tumor Immunity and Immunotherapy for HPV-Related Cancers.

Authors:  Achraf A Shamseddine; Bharat Burman; Nancy Y Lee; Dmitriy Zamarin; Nadeem Riaz
Journal:  Cancer Discov       Date:  2021-05-14       Impact factor: 39.397

Review 9.  The Immune Microenvironment in Human Papilloma Virus-Induced Cervical Lesions-Evidence for Estrogen as an Immunomodulator.

Authors:  Jayshree R S
Journal:  Front Cell Infect Microbiol       Date:  2021-04-30       Impact factor: 5.293

10.  The invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system.

Authors:  Agnieszka K Grabowska; Angelika B Riemer
Journal:  Open Virol J       Date:  2012-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.